IvyRock Asset Management HK Ltd purchased a new stake in SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) in the 4th quarter, according to its most recent disclosure with the SEC. The fund purchased 6,000 shares of the exchange traded fund’s stock, valued at approximately $732,000. SPDR S&P Biotech ETF accounts for 0.4% of IvyRock Asset Management HK Ltd’s holdings, making the stock its 10th largest position.
Several other hedge funds and other institutional investors have also modified their holdings of XBI. Legacy Wealth Managment LLC ID acquired a new position in SPDR S&P Biotech ETF during the 4th quarter valued at about $32,000. Ballast Advisors LLC acquired a new position in SPDR S&P Biotech ETF during the 4th quarter valued at about $36,000. Creative Financial Designs Inc. ADV acquired a new position in SPDR S&P Biotech ETF during the 4th quarter valued at about $39,000. Navalign LLC acquired a new position in SPDR S&P Biotech ETF during the 4th quarter valued at about $48,000. Finally, Barnes Dennig Private Wealth Management LLC acquired a new position in SPDR S&P Biotech ETF during the 4th quarter valued at about $48,000.
SPDR S&P Biotech ETF Stock Up 2.8%
SPDR S&P Biotech ETF stock opened at $133.42 on Friday. The firm has a 50-day moving average price of $131.81 and a two-hundred day moving average price of $126.55. The firm has a market capitalization of $8.51 billion, a price-to-earnings ratio of 11.47 and a beta of 0.85. SPDR S&P Biotech ETF has a 52-week low of $80.90 and a 52-week high of $139.19.
SPDR S&P Biotech ETF Company Profile
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.
Further Reading
- Five stocks we like better than SPDR S&P Biotech ETF
- The Great AI Server Rotation Puts Hewlett Packard Enterprise and Super Micro Computer in Focus
- Generac’s AI Power Pivot Raises a Bigger Question About Data Center Demand
- Medtronic Bottoms, Healthy Rebound Ahead
- GitLab’s Price Recovery Gains Traction—Time to Get On Board?
Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report).
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.
